Inventor

David Baker

Inventor
Seattle, WA, US

Overview

51→
Patents
1977–2021
Patent span
Chemistry
Primary field (CPC C)

Patents· 51 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

C07Kprimary
C07KPeptides17%
A61KPreparations for medical, dental or toiletry purposes13%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations11%
G01NInvestigating or analysing materials by determining their chemical or physical properties11%
C12NMicroorganisms or enzymes10%
C07DHeterocyclic compounds9%
C12YEnzymes6%
G16BBioinformatics, i.e. information and communication technology [ict] specially adapted for genetic or protein-related data processing in computational molecular biology6%
C07HSugars5%
Y10STechnical subjects covered by former uspc cross-reference art collections [xracs] and digests4%
PatentTitleYear
11,028,383Polypeptide assemblies and methods for the production thereof202110,851,135De novo design of protein switches202010,844,105De novo design of potent and selective interleukin mimetics202010,829,756Discovery of enzymes from the alpha-keto acid decarboxylase family202010,818,377Computational design of self-assembling cyclic protein homo-oligomers202010,766,929De novo designed hemagglutinin binding proteins202010,703,791De novo design of potent and selective interleukin mimetics202010,688,330Isolated phosphotriesterase polypeptides, polynucleotides encoding same and uses thereof in treating or preventing organophosphate exposure associated damage202010,501,733Polypeptide assemblies and methods for the production thereof201910,351,603Polypeptides for use in self-assembling protein nanostructures201910,248,758Self-assembling protein nanostructures20199,840,539'High affinity digoxigenin binding proteins'20179,778,261'Porous membrane-binding peptides'20179,771,395'Enhanced influenza hemagglutinin binders'20179,766,255'Biosensors engineered from conditionally stable ligand-binding domains'20179,750,814'Polypeptides to inhibit epstein barr viral protein BHRF1 and B cell lymphoma family proteins'20179,630,994'Polypeptides for use in self-assembling protein nanostructures'20179,624,272'Polypeptides for treating and/or limiting influenza infection'20179,493,547'Binding proteins to the constant region of immunoglobulin G'20169,388,217'Polypeptides for treating and/or limiting influenza infection'20169,243,238'Synthetic enzymes derived from computational design'20169,181,300'Polypeptides for treating and/or limiting influenza infection'20158,969,521'General method for designing self-assembling protein nanomaterials'20158,765,686'Polypeptides for treating and/or limiting influenza infection'20148,754,034'Structure-based design of peptide inhibitors of amyloid fibrillation'20148,688,427'Enzyme catalysts for diels-alder reactions'20148,343,487'Large-scale production of soluble hyaluronidase'20138,340,951'Synthetic enzymes derived from computational design'20128,187,855'Large-scale production of soluble hyaluronidase'20127,910,714'Monomeric red fluorescent proteins'20117,671,185'Monomeric red fluorescent proteins'20107,574,306'Method and system for optimization of polymer sequences to produce polymers with stable, 3-dimensional conformations'20097,250,298'Monomeric red fluorescent proteins'20076,562,850'Methods of synthesizing sultams and anti-viral compositions'20036,458,962'Sultams: catalyst systems for asymmetric reduction of a CN intermediate biological compositions and methods for making the sultams'20026,353,112'Sultams: Solid phase and other synthesis of anti-HIV compounds and compositions'20026,046,228'Anti-viral pharmaceutical compositions containing saturated 1,2-dithiaheterocyclic compounds and uses thereof'20005,843,990'Pyran-chromenone compounds, their synthesis and anti-HIV activity'19985,608,085'Synthesis of optically active calanolides A and B and enantiomers and related compounds'19975,019,573'Substituted dibenzofurans and methods of using same'19914,845,101'Pyrazine diazohydroxide compositions and method of use as cytostatic agent'19894,816,468'5-cyanopyridine-2-diazohydroxide, basic salts and use'19894,709,033'Pyrazine diazohydroxide compounds and methods for their production and use'19874,636,564'5-cyanopyridine-2-diazohydroxide, basic salts and methods for production and use'19874,212,941'Method for the production of 9-(2-O-acyl-.beta.-D-arabinofuranosyl)adenine compounds'19804,195,176'Imidazole compounds, methods for their production and conversion of said compounds into (R)-3-(2-deoxy-.beta.-D-erythro-pentofuranosyl)-3,6,7,8-tetrahydroimidaz ol[4,5-d][1,3]diazepin-8-ol'19804,117,229'2-Amino-1-(5-amino-1H-imidazol-4-yl)ethanone and method of preparation'19784,069,382'9-(5-O-Acyl-.beta.-D-arabinofuranosyl)adenine compounds'19784,055,717'9-(3-O-Acyl-.beta.-D-arabinofuranosyl)adenine compounds, 9-(2,3-di-O-acyl-.beta.-D-arabinofuranosyl)-adenine compounds, and method for their production'19774,055,718'9-(2-O-Acyl-.beta.-D-arabinofuranosyl)-adenine compounds and method for their production'19774,048,432'9-(3,5-Di-O-acyl-.beta.-D-arabinofuranosyl)adenine compounds and method for their production'1977

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

1977–1978Patents assigned to PARKE DAVIS & CO (4)· patent assignee history
1977–1980Based in Ann Arbor, MI, US· patent location history
1987–1989Patents assigned to UNIV ALABAMA (4)· patent assignee history
1987–1991Based in Tuscaloosa, AL, US· patent location history
1997–2003Patents assigned to UNIV TENNESSEE RES CORP (4)· patent assignee history
1997–2003Based in Knoxville, TN, US· patent location history
2007–2021Patents assigned to UNIV WASHINGTON (23)· patent assignee history
2007–2021Based in Seattle, WA, US· patent location history
2012–2016Patents assigned to BAKER DAVID (7)· patent assignee history
2012–2013Based in San Diego, CA, US· patent location history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
UNIV WASHINGTON232007–2021
BAKER DAVIDself72012–2016
PARKE DAVIS & CO41977–1978
UNIV ALABAMA41987–1989
UNIV TENNESSEE RES CORP41997–2003
Locations
LocationPatentsSpan
Seattle, Washington, US312007–2021
Ann Arbor, MI, US71977–1980
Knoxville, TN, US61997–2003
Tuscaloosa, AL, US51987–1991
San Diego, California, US22012–2013